Emerging infectious diseases like Ebola, MERS, CRE, and C auris pose significant public health threats, requiring effective infection control measures.

New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility

New diagnostic tools, increased human exposure, and emergence of more virulent bacterial strains contribute to the emergence of 26 major emerging and reemerging infectious diseases from bacterial origin.

Emerging bacterial pathogens: the past and beyond

Emerging pathogens require vigilance and collaboration among public health and healthcare providers to contain outbreaks and prevent transmission.

Emerging viral diseases and infectious disease risks

Emerging viral infections, such as West Nile Virus, Crimean-Congo Hemorrhagic Fever, and Hepatitis E virus, pose a significant occupational health risk, with outdoor workers at risk from exposure to infected mosquitoes and ticks.

Emerging zoonotic viral infections of occupational health importance

Emerging and re-emerging viral infections pose a significant public health threat, with potential for global spread due to rapid human mobility and global airline networks.

Impact of Emerging, Re-Emerging and Zoonotic Viral Infectious Diseases, in a Virologist’s Perspective

Developing effective vaccines against emerging and re-emerging viruses is crucial for global health and economic recovery, but challenges and hurdles must be overcome for rapid and massive coverage.

Viral Emerging Diseases: Challenges in Developing Vaccination Strategies

Tissue tropism and transmission biology can predict the virulence of human RNA viruses, with systemic infection, renal and neural tropism, direct contact or respiratory transmission, and limited human-to-human transmissibility being the strongest predictors of severe disease.

Tissue tropism and transmission ecology predict virulence of human RNA viruses

Emerging and re-emerging viral epidemics pose significant health risks, and understanding their emergence and re-emergence can help prepare for future threats.

Emerging and emerging viruses

Emerging viruses pose a major public health challenge, with climate change, international migration, deforestation, and other anthropogenic activities contributing to their emergence and re-emergence.

Special Issue “Emerging Viruses: Surveillance, Prevention, Evolution, and Control”

Emerging virus diseases pose a major threat to human and veterinary public health, with environmental changes, urbanization, and human behavior driving their emergence.

Emerging virus diseases: can we ever expect the unexpected?

Emerging and reemerging fatal viral diseases, such as coronaviruses and SARS-CoV-2, pose a global health threat due to their ability to evade host immune responses and adapt to new host species.

Emerging and re-emerging fatal viral diseases

Influenza viruses evolve in reservoir hosts and adapt to humans, leading to pandemics and seasonal viruses, with mechanisms still unclear for zoonotic infection and new host adaptation.

Influenza virus evolution, host adaptation, and pandemic formation.

Virus-bacteria interactions play a crucial role in promoting or causing human infections, with direct interactions aiding viruses and indirect interactions increasing bacterial pathogenesis.

Virus-Bacteria Interactions: An Emerging Topic in Human Infection

Emerging respiratory tract infections and antimicrobial resistance pose a global health security threat, requiring improved surveillance, early detection, and effective management strategies.

Emerging respiratory tract infections

New diagnostic methods, such as multiplex nucleic acid amplification and microarray-based assays, are emerging for timely and effective detection of respiratory virus infections in humans.

Recent advances in the detection of respiratory virus infection in humans

Effective surveillance systems are needed to identify and monitor emerging respiratory epidemics and diseases with epidemic potential, enhancing global health security.

Surveillance for emerging respiratory viruses

Emerging and reemerging viruses infecting humans include novel viruses, previously unknown pathogens, and those with increased impact on human health, highlighting the need for increased surveillance and detection technologies.

Editorial overview: Emerging viruses

Novel antivirals are crucial for treating influenza, respiratory syncytial virus, and Middle East respiratory syndrome coronavirus infections, as current treatments are limited by antigenic drift and antigenic shift.

Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections

Vaccine intervention for emerging viruses is possible due to molecular techniques, a range of strategies, and international commitment, making rapid vaccine development a critical component of disease prevention.

Emerging viruses and current strategies for vaccine intervention

Newly emerging viruses pose a global health threat, with novel and variants of existing viruses posing significant risks.

New Emerging Viruses

What are the health implications of emerging viruses and bacteria?

These studies suggest that emerging viruses and bacteria pose significant public health threats, driven by factors such as environmental changes, increased human exposure, and global mobility, requiring effective infection control, diagnostic tools, vaccines, and collaboration among health providers.